News from us and our partners

Tags

Topics

0 results

News
15 June, 2020
Epsilen Bio appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board
News
12 June, 2020
Synthace and Tecan Announce Collaboration to Accelerate Purification Optimization in Process Development through Augmented Lab Automation
News
11 June, 2020
Sofinnova Partners announces sale of Corvidia Therapeutics to Novo Nordisk
News
11 June, 2020
AFYREN and the AFTER-BIOCHEM European consortium obtain a funding of 20 million euros for the industrial production of new bio-based products
News
10 June, 2020
Protera Closes $5.6M Series A Financing led by Sofinnova Partners
News
9 June, 2020
Mainstay Medical wins reimbursement approval for ReActiv8 in Australia
News
9 June, 2020
Shockwave Medical Announces That CMS Has Created New Codes for Intravascular Lithotripsy
News
9 June, 2020
Biotalys expands executive team and establishes U.S. headquarters to strengthen North American presence
News
5 June, 2020
Calliditas Therapeutics Prices its Initial Public Offering on The Nasdaq Global Select Market in the United States
News
3 June, 2020
NodThera Announces Close of $55 Million Series B Financing
News
31 May, 2020
RGENIX Shows Clinical Activity of Novel Agent RGX-202 in Patients with KRAS Mutant Colorectal Cancer in Phase 1 Trial
News
28 May, 2020
RefleXion Announces Clinical Collaboration to Evaluate Biology-guided Radiotherapy with Merck’s KEYTRUDA® for Certain Late-Stage Cancers
News
26 May, 2020
Biotalys awarded €1.6 million VLAIO research grant
News
25 May, 2020
Abivax Announces German Regulatory Approval of ABX464 Covid-19 Phase 2b/3 COVID-19 Clinical Trial
News
22 May, 2020
Comet Bio reports positive clinical results for Arrabina prebiotic
News
21 May, 2020
HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines

Epsilen Bio appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board

Synthace and Tecan Announce Collaboration to Accelerate Purification Optimization in Process Development through Augmented Lab Automation

Sofinnova Partners announces sale of Corvidia Therapeutics to Novo Nordisk

AFYREN and the AFTER-BIOCHEM European consortium obtain a funding of 20 million euros for the industrial production of new bio-based products

Protera Closes $5.6M Series A Financing led by Sofinnova Partners

Mainstay Medical wins reimbursement approval for ReActiv8 in Australia

Shockwave Medical Announces That CMS Has Created New Codes for Intravascular Lithotripsy

Biotalys expands executive team and establishes U.S. headquarters to strengthen North American presence

Calliditas Therapeutics Prices its Initial Public Offering on The Nasdaq Global Select Market in the United States

NodThera Announces Close of $55 Million Series B Financing

RGENIX Shows Clinical Activity of Novel Agent RGX-202 in Patients with KRAS Mutant Colorectal Cancer in Phase 1 Trial

RefleXion Announces Clinical Collaboration to Evaluate Biology-guided Radiotherapy with Merck’s KEYTRUDA® for Certain Late-Stage Cancers

Biotalys awarded €1.6 million VLAIO research grant

Abivax Announces German Regulatory Approval of ABX464 Covid-19 Phase 2b/3 COVID-19 Clinical Trial

Comet Bio reports positive clinical results for Arrabina prebiotic

HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines